Pharmaceutical Product Monograph: Celecoxib Capsules (100 mg / 200 mg)
In the pharmaceutical industry, Celecoxib is a diaryl-substituted pyrazole and a potent Non-Steroidal Anti-Inflammatory Drug (NSAID). As a pharmacist and manufacturer, I classify this as a “Selective Specialist”—it is technically a COX-2 Inhibitor, designed to block the enzymes that cause pain and inflammation while sparing the COX-1 enzymes that protect the stomach lining.
At your WHO-GMP facility in Mumbai, Celecoxib is a high-value SKU for Orthopedic, Rheumatology, and Pain Management portfolios. It is the preferred alternative for patients who cannot tolerate traditional NSAIDs like Ibuprofen or Diclofenac due to gastric sensitivity.
Therapeutic Profile: Primary Indications
Celecoxib is indicated for the relief of signs and symptoms of several chronic and acute inflammatory conditions.
| Indication | Clinical Context | Technical Rationale |
| Osteoarthritis (OA) | Geriatric Care | Reduces joint pain and stiffness with lower risk of GI bleeding in elderly patients. |
| Rheumatoid Arthritis (RA) | Autoimmune | Manages chronic inflammation and joint swelling in adults and juveniles. |
| Ankylosing Spondylitis | Spinal Health | First-line treatment for reducing pain and improving spinal mobility. |
| Acute Pain | Post-Surgical / Dental | Effective for short-term management of acute pain and primary dysmenorrhea (period cramps). |
| FAP Management | Oncology | Historically used to reduce the number of adenomatous colorectal polyps in Familial Adenomatous Polyposis. |
Mechanism: Selective COX-2 Inhibition
Celecoxib works by sabotaging the production of inflammatory chemicals without harming the “good” ones:
Enzyme Targeting: It specifically binds to the Cyclooxygenase-2 (COX-2) enzyme, which is induced during inflammation.
Prostaglandin Blockade: By inhibiting COX-2, it stops the synthesis of Prostaglandins ($PGE_2$), the primary mediators of pain and swelling.
COX-1 Sparing: Unlike Aspirin, it does not significantly inhibit COX-1 at therapeutic doses. This means the protective mucus lining of the stomach remains intact.
Anti-Pyretic Action: Like most NSAIDs, it also helps reduce fever by acting on the heat-regulating center of the hypothalamus.
The Pharmacist’s “Technical Warning”
The “Sulfonamide” Allergy: Celecoxib contains a sulfonamide moiety. It is strictly contraindicated in patients with a known “Sulfa” allergy.
Cardiovascular Risk: Like all COX-2 inhibitors, it carries a “Black Box Warning” for increased risk of serious cardiovascular thrombotic events (myocardial infarction and stroke). It should be used at the lowest effective dose for the shortest duration.
Asthma Interaction: Avoid in patients who have experienced asthma or allergic-type reactions after taking Aspirin or other NSAIDs.
Renal Monitoring: Chronic use can lead to renal papillary necrosis; baseline kidney function tests are recommended for long-term therapy.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at Healthy Life Pharma / Healthy Inc:
The “Bioavailability” USP: Celecoxib is highly lipophilic (fat-soluble). On your digital marketplace, highlight your Micronization technology or specialized excipient mix that ensures rapid dissolution and consistent absorption ($T_{max}$ of ~3 hours).
The “Gastric-Safe” Market: Position this as the “Premium Pain Solution” for the private hospital sector. It commands a higher price point than generic Diclofenac because of its superior GI safety profile.
Stability in Export: Celecoxib is relatively stable, but ensure your Alu-Alu or PVC/PVDC blisters are validated for high-temperature zones to prevent any change in the crystalline structure of the active ingredient.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Celecoxib 100/200 mg to support your registration in international B2B markets.